Stock Quote

Gilead Sciences agrees to sell Europe up to 500,000 courses of remdesivir

Deal with European Commission comes amid a surge in COVID-19 cases across Europe.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.